Pyrolysis Residue Testing for Medical Adhesives: Methods, Standards, and Technical Applications

Pyrolysis residue testing is a critical analytical approach for evaluating the thermal stability and degradation behavior of medical adhesives used in wound care, transdermal systems, and device assembly. By characterizing the residue and decomposition products formed when adhesives are exposed to elevated temperatures, manufacturers can verify sterilization compatibility, support biocompatibility assessments, and demonstrate regulatory compliance. This article outlines the sample types, testing parameters, analytical methods, and quality applications involved in medical adhesive pyrolysis residue evaluation.

Technical Overview

Medical adhesives are polymeric materials—typically acrylic pressure-sensitive adhesives, silicone gels, cyanoacrylates, polyurethanes, or hydrogels—designed to bond skin, substrates, or device components under clinically relevant conditions. Throughout their life cycle, these materials are routinely exposed to thermal stress from steam sterilization, ethylene oxide cycles with heated aeration, dry-heat processes, laser cutting of adhesive laminates, hot-melt application, accelerated aging studies, and device operating environments. When the thermal energy exceeds the stability limits of the polymer backbone, crosslinking network, or additives, the adhesive undergoes pyrolytic degradation.

Pyrolysis residue refers to the non-volatile matter that remains after controlled thermal decomposition of the adhesive. This residue may include carbonaceous char, inorganic fillers, silica reinforcement, catalyst residues, pigments, and mineral additives, while the volatile fraction generates monomers, oligomers, aldehydes, ketones, acids, and other low-molecular-weight degradation products. Quantifying both the residue fraction and the identity of evolved species provides essential data for:

• Sterilization process compatibility and validation (for example, ISO 17665 for moist heat or ISO 11135 for ethylene oxide)
• Chemical characterization of materials within biological evaluation frameworks such as ISO 10993-18 and toxicological risk estimation under ISO 10993-17
• Material selection and formulation screening during design and development
• Lot-release quality control and incoming adhesive inspection
• Failure analysis of discolored, embrittled, delaminated, or odorous adhesive layers after heat exposure

Because degradation products may migrate from the adhesive into skin, drug formulations, or adjacent device components, pyrolysis residue testing is closely linked to extractables and leachables (E&L) programs and to overall biological safety documentation required for regulatory submissions.

Testing Samples

Acrylic Pressure-Sensitive Adhesives

Solvent-based, water-based, or UV-cured acrylic PSAs used in wound dressings, surgical tapes, fixation films, and medical electrodes. Testing focuses on residual monomer release, chain-scission volatiles, and any inorganic residue from tackifiers or fillers after thermal decomposition.

Silicone Medical Adhesives and Gels

Soft silicone adhesives used for scar management sheets, gentle-wound-contact layers, and transdermal backing laminates. Pyrolysis evaluation addresses siloxane cyclic oligomers, platinum catalyst residues, and silica-reinforcement ash content.

Cyanoacrylate Tissue Adhesives

In-situ polymerizing n-butyl or 2-octyl cyanoacrylate formulations. Thermal characterization identifies decomposition products such as formaldehyde and alkyl cyanoacetate, which are relevant to local toxicological assessment.

Polyurethane and Hot-Melt Assembly Adhesives

Structural adhesives used in catheter bonding, device housing assembly, and nonwoven lamination. Testing evaluates isocyanate-derived degradation species, urethane bond cleavage products, and residue from inorganic additives or flame retardants.

Hydrogel and Matrix Adhesives

High-water-content hydrogels for ECG electrodes and drug-in-adhesive matrices for transdermal delivery systems. Testing determines residual crosslinker behavior, monomer volatiles, and ionic or gelling-agent residues remaining after thermal exposure.

Finished Components and Laminates

Converted products such as coated roll stock, die-cut parts, finished dressings, and sterilized packaging assemblies, tested in their as-received, post-sterilization, or post-aging state to reflect real-world thermal history.

Testing Items

Typical test parameters reported for medical adhesive pyrolysis residue evaluation include:

• Pyrolysis residue mass fraction (char and inorganic ash) at defined end-set temperatures
• Onset decomposition temperature, peak degradation temperature, and degradation step analysis
• Total mass loss and residue-on-ignition values under inert and oxidative atmospheres
• Identification and semi-quantification of volatile pyrolysis products (monomers, oligomers, aldehydes, ketones, acids, siloxanes)
• Residual monomer and residual solvent content before and after thermal exposure
• Inorganic elemental composition of the residue (silicon, calcium, aluminum, titanium, zinc, platinum, and trace metals)
• Extractables and leachables profiles of thermally stressed adhesive samples
• Comparative residue data between pre- and post-sterilization or accelerated-aged conditions

Testing Methods

Pyrolysis residue characterization is performed using a combination of thermal analysis and hyphenated chromatographic-spectrometric techniques within accredited third-party laboratories or internal analytical facilities:

Thermogravimetric Analysis (TGA)

TGA measures continuous mass loss as the adhesive is heated, typically from ambient temperature to 600–800 °C, under nitrogen or air purge. The residual mass at the final temperature represents the inorganic or char residue, while stepwise mass losses reveal moisture, volatiles, polymer decomposition, and filler content. Relevant practices include ISO 11358 for thermogravimetry of polymers and ASTM E1131 for compositional analysis by TGA.

Residue on Ignition (Ash Testing)

A gravimetric method in which a weighed adhesive sample is charred, moistened, and ignited in a muffle furnace at approximately 600 °C. The resulting ash is weighed to determine total inorganic residue, consistent with pharmacopeial conventions such as USP and Ph. Eur. residue-on-ignition monographs.

Pyrolysis-Gas Chromatography-Mass Spectrometry (Py-GC/MS)

A microgram-to-milligram adhesive sample is pyrolyzed rapidly at a controlled temperature (commonly 500–700 °C), and the evolved fragments are separated by GC and identified by MS. This technique produces a chemical "fingerprint" of degradation products, enabling identification of monomers, oligomers, additives, and additive decomposition species.

Evolved Gas Analysis (TGA-FTIR and TGA-MS)

Coupling TGA with Fourier-transform infrared spectroscopy or mass spectrometry allows real-time identification of gases evolved at each degradation step, linking specific mass-loss events to chemical species such as carbon dioxide, aldehydes, hydrocarbons, or cyclic siloxanes.

Headspace GC-MS and Residual Solvent Analysis

Static or dynamic headspace GC-MS quantifies residual monomers and processing solvents released after defined thermal conditioning, supporting chemical characterization under ISO 10993-18 and residual solvent guidance aligned with ICH Q3C conventions.

Inorganic Elemental Analysis

The isolated residue is digested and analyzed by ICP-MS, ICP-OES, or X-ray fluorescence to determine its inorganic elemental composition, including heavy metals and catalyst traces relevant to toxicological evaluation under ISO 10993-17.

Supporting Thermal and Spectral Methods

Differential scanning calorimetry (ISO 11357) identifies transitions affected by degradation, FTIR spectroscopy detects chemical changes such as oxidation or carbonyl formation, and surface techniques such as SEM-EDS characterize residue morphology and elemental distribution.

Applications

Pyrolysis residue testing supports multiple stages of the medical adhesive and medical device life cycle:

• Sterilization compatibility: verifying that steam, ethylene oxide, gamma, or e-beam sterilization conditions do not generate unacceptable degradation products or residue changes in the adhesive layer.
• Biocompatibility and chemical characterization: generating degradation-product data that feed into ISO 10993-1 biological evaluation plans, ISO 10993-18 material characterization, and ISO 10993-17 toxicological risk assessments.
• Regulatory submissions: providing technical evidence for device master files, CE marking technical documentation under the EU MDR, and premarket submissions to authorities such as the FDA.
• Process development: defining safe processing windows for hot-melt coating, drying ovens, die-cutting, and laser cutting of adhesive webs where localized heating occurs.
• Shelf-life and stability studies: comparing residue and degradation profiles before and after real-time and accelerated aging per ASTM F1980 conventions for sterile barrier systems.
• Quality control: establishing lot-release acceptance criteria for residue content, decomposition temperature, and volatile degradation markers.
• Failure analysis: diagnosing root causes of adhesive discoloration, odor generation, loss of tack, cohesive failure, or skin irritation linked to thermal degradation.

FAQ

What is the difference between pyrolysis residue and ash content?

Pyrolysis residue is the total non-volatile matter remaining after thermal decomposition, which may include carbonaceous char and inorganic species. Ash content specifically refers to the inorganic residue after complete ignition of organic matter, typically determined by residue-on-ignition methods at controlled furnace temperatures.

Why is pyrolysis residue testing important for medical adhesives?

Thermal exposure during sterilization, processing, or storage can break down adhesive polymers and generate degradation products that may migrate to skin, drugs, or device components. Residue and evolved-species data confirm thermal stability, support biocompatibility conclusions, and protect patient safety.

How much sample is required for testing?

TGA and Py-GC/MS typically require only milligram-scale quantities, while residue-on-ignition and elemental analysis may require tens to hundreds of milligrams depending on adhesive loading and substrate configuration. Free films are preferred where possible to minimize substrate interference.

Which standards govern this testing?

There is no single mandatory pyrolysis residue standard for medical adhesives; testing is typically structured around ISO 10993-18 for chemical characterization, ISO 10993-17 for toxicological assessment, ISO 11358 and ASTM E1131 for thermogravimetric methods, and sterilization standards such as ISO 11135 and ISO 17665 for process context.

Can finished products be tested, or only raw adhesive?

Both can be evaluated. Raw adhesive or free films provide the clearest polymer-specific data, while finished laminates and sterilized products reflect actual thermal history and are valuable for compatibility validation and stability studies. Substrate contribution must be accounted for in interpretation.

How should results be interpreted?

Residue values and degradation-product profiles are compared against formulation baselines, historical lot data, and toxicological reference thresholds. Significant shifts in decomposition temperature, residue mass, or evolved-species identity after sterilization or aging may indicate material instability requiring formulation or process adjustment.